| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.29 | 1e-15 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.27 | 3e-15 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.25 | 4e-13 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.26 | 1e-09 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.24 | 1e-09 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-09 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.26 | 5e-09 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.21 | 9e-09 |